Projects funded by the NCN
New hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)-propanamide in the search for substances effective in treatment of drug resistant epilepsy
2018/29/N/NZ7/01966
Keywords:
Hybrid compounds amino acid derivatives pyrrolidine-2,5-dione drug resistant epilepsy 6 Hz (44 mA) seizure test MAO-B inhibitors
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 15 - announced on 2018-03-15
Amount awarded: 208 880 PLN
Project start date (Y-m-d): 2019-03-29
Project end date (Y-m-d): 2023-03-28
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.